The Egyptian Ministry of Petroleum and Schlumberger have announced the launch of the Egypt Upstream Gateway, an innovative national project for the digitalization of subsurface information. This digital platform will also enable global access to the country s subsurface data, which is kept evergreen by enhancing legacy datasets through reprocessing and new studies.
Biofriendly Partners with Gulf Oil Mexico
Biofriendly s Green Plus® energy transition fuel Now Available at Gulf Gas Stations
News provided by
Share this article
Share this article
LOS ANGELES, Feb. 18, 2021 /PRNewswire/ Biofriendly Corporation, the green solutions company, has partnered with Gulf Oil Mexico to provide
Green Plus energy transition fuel for gas stations across Mexico. This partnership helps Gulf Oil Mexico get another step closer to reaching the Sustainable Development Goals set by the United Nations for 2030. Since partnering with Biofriendly in July 2020, Gulf Oil has seen a 35% increase in sales, proving that energy transition fuel is resonating with customers.
/PRNewswire/ Chris Webber, entrepreneur, five-time NBA All-Star and Founder of Webber Wellness, today announced a partnership with Jason Wild and JW Asset.
Ghaziabad: The health department on Monday revoked the licence of a nursing home in Loni area for allegedly carrying out sex determination tests.
Officials said that Krishna Nursing Home in Behta had been conducting the tests using an unregistered ultrasound machine. The owner of the facility and another person have been arrested in the case.
Three foetuses, all of which are about three month old, were found in the building. They have been sent for post-mortem, officials said.
The crime came to light after a Faridabad health department team reached Ghaziabad and a woman visited the nursing home on Sunday posing as a customer and reported the incident. The nursing home officials allegedly took Rs 15,000 from the woman for a sex determination test.
(1) In this collaboration Almirall will commercialize Wynzora Cream for treatment of plaque psoriasis in Europe and MC2 Therapeutics will be responsible for manufacturing and supply.
MC2 Therapeutics and Almirall partner to make Wynzora Cream a leading topical product for Plaque Psoriasis in Europe
In a large European based Phase 3 clinical trial (n=490), Wynzora Cream has demonstrated substantial efficacy with a PGA treatment success of 51% and beneficial treatment convenience
1 Cream has been filed and approval is expected this year
Almirall S.A. (BME: ALM), a global biopharmaceutical company and
MC2 Therapeutics, a commercial stage pharmaceutical company developing a new standard within topical therapies for autoimmune and chronic inflammatory conditions, announced today an agreement under which MC2 Therapeutics has granted Almirall exclusive European rights to commercialize Wynzora